WATERTOWN, Mass.–(BUSINESS WIRE)–#CEO–Lyndra today announced the appointment of Dr. Patricia Hurter as Chief Executive Officer, effective September 3.
http://www.businesswire.com/news/home/20190602005048/en/Lyndra-Therapeutics-Welcomes-Dr.-Patricia-Hurter-Chief/